Palliative Care Impact Survey

Size: px
Start display at page:

Download "Palliative Care Impact Survey"

Transcription

1 September 2018

2 Contents Introduction...3 Headlines...3 Approach...4 Findings...4 Which guideline are used...4 How and where the guidelines are used...6 Alternative sources of information...7 Use of the guidelines in practice...9

3 Introduction The purpose of the Scottish Palliative Care Guidelines is to provide in a readily usable format, practical, evidence-based or best-practice guidance on a range of common clinical issues. These Palliative Care Guidelines reflect a consensus of opinion about good practice in the management of adult patients with life limiting illnesses. They have been developed by a multidisciplinary group of professionals working in the community, hospital and specialist palliative care services. In order to assess the impact of the guidelines on patient care, a survey was circulated to palliative care networks and published on the guidelines website. The survey asked five questions to establish which guidelines are most used, how they are used in practice and what alternative sources of information practitioners use. This report provides an overview of the findings and provides an insight into the use of the guidelines in practice. Headlines Responses 44 Completed responses Most popular guidelines top five: Anticipatory Prescribing Care in the Last Days of Life Choosing and Changing Opioids Nausea and Vomiting Syringe Pumps 3

4 Approach A survey aimed at practicing clinicians was promoted online and through social media asking: Which guideline or guidelines did you use? (Select as many as appropriate) Describe briefly what the situation was (i.e. location of care, nature of symptoms) What did you do as a result of using the guidelines? (e.g. action taken or not taken, drug prescribed) What would you have done if the guidelines had not been available? How did use of the guideline impact on your patient or their family? How we have analysed and presented the results: Data from the survey responses is presented to give an overview of respondents use of the guidelines and alternative information sources Specific responses to some of the questions have been collated to present as case studies of how the guidelines are used in practice. Findings Which guideline are used Q1: Which guideline or guidelines did you use? (Select as many as appropriate) 42 responses to this question. Listed from most to least used: Anticipatory Prescribing 28 Choosing and Changing Opioids 28 Syringe Pumps (Subcutaneous medication & compatibility charts) 28 Care in the Last Days of Life 26 Nausea and Vomiting 25 Bowel Obstruction 19 Alfentanil 18 Breathlessness 18 Fentanyl Patches 16 Levomepromazine 16 Midazolam 16 Pain Management 16 Mouth Care 15 Constipation 14 Seizures 14 Delirium 13 Hiccups 13 4

5 Ketamine 13 Neuropathic Pain 13 Fentanyl Sublingual (Abstral) 12 Hypercalcaemia 11 Malignant spinal cord compression 11 Oxycodone 11 Renal Disease in the Last Days of Life 11 Bleeding 10 Pain Assessment 10 Weakness / Fatigue 10 Cough 9 Severe uncontrolled distress 9 Anorexia/Cachexia 8 Fentanyl Nasal Spray (Pecfent) 8 Lidocaine 8 Pain Assessment - Cognitive Impairment 8 Pruritis 8 Methadone 7 Naloxone 7 Octreotide 7 Subcutaneous Fluids 7 Depression 6 Fentanyl Buccal (Effentora) 6 Out of Hours Handover 6 Phenobarbital (Phenobarbitone) 6 Superior Vena Cava Obstruction 6 Sweating 6 Diarrhoea 4 Methylnaltrexone 4 Rapid Transfer Home in the Last Days of Life 4 5

6 How and where the guidelines are used Q2: Describe briefly what the situation was (i.e. location of care, nature of symptoms) 38 responses to this question Location of care: Acute: 17 Community / Primary: 10 Unknown / Mixed: 9 Medicines Info: 2 Uses these common themes emerged in the answers to question two: Teaching Prescribing Symptom management Confirm own knowledge Supplement own knowledge 6

7 Regularity of use, some quotes: "I use the guidelines to underpin all of my teaching" "I use the guidelines on a daily to weekly basis. " "I use the palliative care guidelines on a weekly basis (on average)." " I frequently refer to the guidelines - and also encourage others to use them." "...on daily basis" Alternative sources of information Q4: What would you have done if the guidelines had not been available? 42 responses: Consulted another information source (please describe) 66.7% Other (please describe) 0.0% Used my own clinical knowledge and judgement 45.2% Consulted a colleague 69.0% 7

8 Alternative information sources: Web tools, guidelines, journals, books etc. BNF, EMC, CKS, Pallcare.info (PANG), Martindale, SPC, Drugdex, AHFS, palliativedrugs.com (PCF) Local formulary or guidance, Intranet, Local health board pharmaceutical update, Guidelines from other health boards Syringe driver book Embase, Medline Oxford handbook of palliative care / of oncology Internet search Palliative care research and other expert texts, recent medical and nursing articles Colleagues consulted MDT OOH GP Hospice / hospice consultant Pharmacists Palliative care nurse / team / ward colleagues Consultant Palliative Care Specialist Pharmacist Medicines Information Other comments I may use other resources in addition to the Scottish Palliative Care guidelines to answer enquiries. However, they are a very valuable resource that I often direct enquirers to. Very easy to read, laid out very well, reliable information Would have looked for other resources but would have struggled to find the same detailed information. I am afraid I did not know that there were National Palliative Care Guidelines. I have never accessed them because I did not know about them. I generally make an assessment about symptom relief and start treatment and ask for support from the Palliative Care team, knowing that their input will be invaluable both in terms of symptom control but also in focusing on person-centred care for the patient and family. 8

9 Use of the guidelines in practice To illustrate the use of the palliative care guidelines, answers to questions two, three and five are collated below to build a picture of how the guidelines are used in practice and the impact this has on patients and families. Some responses have been edited slightly for brevity and clarity. Q2: Describe briefly what the situation was (i.e. location of care, nature of symptoms) Q3: What did you do as a result of using the guidelines? (e.g. action taken or not taken, drug prescribed) Q5: How did use of the guideline impact on your patient or their family? Case studies Patient with gastric cancer admitted to a surgical ward after frequent hospital admissions for gastric drainage. On this admission, they were referred to the hospital palliative care team due to a complete bowel obstruction and the team wanted advice on nausea and vomiting as the patient was too frail to operate. As the absorption of medications was unclear and the acute nature of the obstruction, I suggested converting MST dose to an appropriate Morphine dose to be given subcutaneously via a syringe driver. I advised against the previously used PRN medication, which was Metoclopramide, this was discontinued and Cyclizine added to the syringe driver, 50mg initially with additional PR doses available. The patient was quite frail so I suggested that anticipatory medications be prescribed and recommended as per the guidelines. I was able to explain to the patient and family that these treatment choices are suggested by the national guidelines and why they were appropriate for this particular condition and situation. The patient died a couple of days later with anticipatory medications available, pain well managed, able to take sips of fluid as preferred until the last stages of their life. The nausea settled itself once the bowel was rested. Patient was at home and had alfentanil in a syringe pump. I used the guidelines to compare opioid doses. Provided advice on use of another analgesia for breakthrough pain and appropriate dose. Appropriate drugs were prescribed if needed for breakthrough pain 9

10 Community hospital setting. The last time I used the guidelines was yesterday to look up bleeding; the midazolam had been prescribed as sub cut and I felt it may be better via IM. Using the bleeding guidelines I felt confident to change the as required dose to IM. I changed the sub cut to IM Ensured appropriate 'just in case' meds prescribed in case of a large bleed event. Patient approaching end of life with terminal distress and agitation, at home being looked after by family. Suggested Levomepromazine for agitation and midazolam for distress in end of life via CSCI with PRN levomepromazine and midazolam prescribed over and above this. Patient settled very quickly and ultimately had a peaceful death. As a rotational pharmacist covering a general medical ward I recently relied upon the Guidelines for reviewing medicines for a patient with end stage renal failure who was being discharged home for end of life care and required management of pain, SOB, agitation and nausea; respiratory secretions were also anticipated to occur. The patient also had PMH of epilepsy and family were keen for an emergency medicine to be available in case of seizures. I was able to check drug compatibility and appropriateness. The palliative care nurse suggested supplying midazolam in case of seizures and the guidelines allowed us to confirm the available formulation and doses for buccal midazolam to allow the family to administer a dose while awaiting medical assistance, as well as sub-cut midazolam (for DN to administer). The patient continued on the combination of medicines via syringe driver that were controlling their symptoms at that time and was discharged home with appropriate PRN doses. The family felt more reassured knowing that they could at least administer the buccal midazolam were the patient to have a seizure. Patient receiving morphine, midazolam and ketamine by pump in community setting. District nurses administering. Pain management was difficult until both ketamine and morphine doses increased - checked guideline for pump combinations, diluents etc. We were able to set up two syringe drivers for patient having read the guidelines - quality of life dramatically increased as a result. Information was available in a concise and easy to understand format allowing the patient to receive treatment quickly and effectively. 10

11 Hospital ward, older adults mental health. Physical deterioration, severe difficulty with swallowing. Due to cognitive impairment was unable to verbally communicate any specific problems example acute pain / discomfort. Was able to put into practice the guidelines for palliative mouth care. Importance of accurate assessment with the aim to provide appropriate treatment management of any identified problems. With on-going assessments carried out as often as the patient s needs required, the patient was comfortable with no sign of discomfort. Priority was also given at all times to respect the patient s dignity during delivering oral care. 11

Renal Palliative Care Last Days of Life

Renal Palliative Care Last Days of Life Renal Palliative Care Last Days of Life Introduction This guideline is an aid to clinical decision-making and good practice for patients with stage 4-5 chronic kidney disease (egfr

More information

Syringe driver in Palliative Care

Syringe driver in Palliative Care Syringe driver in Palliative Care Introduction: Syringe drivers are portable, battery operated devices widely used in palliative care to deliver medication as a continuous subcutaneous infusion over 24

More information

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice. Bedfordshire Palliative Care Palliative Care Medicines Guidance This folder has been produced to support professionals providing palliative care in any setting. Its aim is to make best practice in palliative

More information

PAIN MANAGEMENT Person established taking oral morphine or opioid naive.

PAIN MANAGEMENT Person established taking oral morphine or opioid naive. PAIN MANAGEMENT Person established taking oral morphine or opioid naive. Important; it is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member

More information

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE Reference: DCM029 Version: 1.1 This version issued: 07/06/18 Result of last review: Minor changes Date approved by owner (if applicable): N/A

More information

PAIN MANAGEMENT Patient established on oral morphine or opioid naive.

PAIN MANAGEMENT Patient established on oral morphine or opioid naive. PAIN MANAGEMENT Patient established on oral morphine or opioid naive. Important; It is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member

More information

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT A collaboration between: St. Rocco s Hospice, Bridgewater Community Healthcare NHS Trust, NHS Warrington Clinical Commissioning Group,

More information

Care in the Last Days of Life

Care in the Last Days of Life Care in the Last Days of Life Introduction This guideline is an aid to clinical decision making and good practice in person-centred care for patients who are deteriorating and at risk of dying. The patient

More information

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety Agitation & Anxiety (Exclude or treat REVERSIBLE causes*) Patient is anxious / frightened, but lucid Patient is confused, agitated and / or hallucinating MIDAZOLAM 2.5-5mg s/c (Max total 24 hour dose of

More information

Symptom Management Guidelines for End of Life Care

Symptom Management Guidelines for End of Life Care Symptom Management Guidelines for End of Life Care The following pages are guidelines for the management of common symptoms in the last few days of life. General principles: 1. Consider how symptoms can

More information

Anticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO

Anticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO Anticipatory Medications for End of Life Patients oses must be proportional to the current analgesic medication Please refer ALL patients on Methadone or Ketamine to palliative care team for advice. Patients

More information

Palliative Care Out-of-hours. A resource pack for West Dorset. Contents:

Palliative Care Out-of-hours. A resource pack for West Dorset. Contents: Palliative Care Out-of-hours. A resource pack for West Dorset Contents: Section 1 Supply of drugs DCH Pharmacy hours and arrangements How to contact a community pharmacist out of hours Palliative care

More information

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL Doses of opiates must be proptional to current analgesic medication Please refer ALL patients on Methadone Ketamine to SPCT f advice. Patients

More information

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text] [Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text] Patients with egfr greater than 30mL/min Patients with egfr less than 30mL/min Symptom Drug Dose Symptom Drug Dose

More information

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure. Care of the Dying Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance covers the prescribing and management of patients

More information

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: North Bristol 0117 4146392 UH Bristol 0117

More information

Palliative care for heart failure patients. Susan Addie

Palliative care for heart failure patients. Susan Addie Palliative care for heart failure patients Susan Addie Treatments The most common limiting and distressing complaint is of fatigue and breathlessness. Optimal treatment strategies relieve symptoms, improves

More information

Care of the Dying Management in Severe Renal Failure

Care of the Dying Management in Severe Renal Failure Care of the Dying Management in Severe Renal Failure Clinical Guideline Early recognition of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance

More information

Algorithms for Symptom Management. In End of Life Care

Algorithms for Symptom Management. In End of Life Care Algorithms for Symptom Management In End of Life Care The Use of Drugs Beyond Licence (off label) -The Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK regulates the activity of the

More information

Care of the Dying Management in Severe Renal Failure

Care of the Dying Management in Severe Renal Failure Care of the Dying Management in Severe Renal Failure Clinical Guideline Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance

More information

Diamorphine 4 hour. alfentanil (500microgram/mL) Calculated by dividing 24 hour oral morphine dose by 30

Diamorphine 4 hour. alfentanil (500microgram/mL) Calculated by dividing 24 hour oral morphine dose by 30 If more information is required please seek help from specialist palliative care pioid dose conversion chart, syringe driver doses, rescue/prn doses and opioid patches Use the conversion chart to work

More information

Supportive Care. End of Life Phase

Supportive Care. End of Life Phase Supportive Care End of Life Phase Guidelines for Health Care Professionals In the care of patients with established renal failure who are in the last days of life References: Chambers E J (2004) End of

More information

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life The following pages are guidelines for the management of common symptoms for a person thought to be

More information

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL If a patient is believed to be approaching the end of their life, medication should be prescribed in anticipation

More information

Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth)

Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth) Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth) Policy Number : DC020 Issue Date: October 2014 Review date: October 2016 Policy Owner: Head Community Services Monitor:

More information

What s New 2003? What new treatments? What have you discontinued? More information please!

What s New 2003? What new treatments? What have you discontinued? More information please! What s New 2003? What new treatments? What have you discontinued? More information please! 1 What s New 2003? Submissions = 137 UK = 52 (38%) Doctors = 60% Nurses = 25% Pharmacists = 15% 2 What s New?

More information

End of life prescribing guidance

End of life prescribing guidance End of life prescribing guidance Introduction This guidance has been prepared to ASSIST IN DECISION MAKING for the prescribing and monitoring of medicines useful in the management of symptoms commonly

More information

End of Life Care. Dr Anne Garry Consultant in Palliative Medicine

End of Life Care. Dr Anne Garry Consultant in Palliative Medicine End of Life Care Dr Anne Garry Consultant in Palliative Medicine Concerns voiced both by public and professionals.. Implementation and on-going training highly variable across country Decisions made by

More information

Palliative Prescribing - Pain

Palliative Prescribing - Pain Palliative Prescribing - Pain LAURA BARNFIELD 21/2/17 Aims To understand the classes of painkillers available in palliative care To gain confidence in counselling regarding opiates To gain confidence prescribing

More information

SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRESCRIPTION & ADMINISTRATION RECORD (SPAR) Name: Address: Postcode: Date of Birth: NHS Number:

SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRESCRIPTION & ADMINISTRATION RECORD (SPAR) Name: Address: Postcode: Date of Birth: NHS Number: FILE IN PATIENT S COMMUNITY HEALTH RECORD FOLDER : SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRERIPTION & ADMINISTRATION RECORD (SPAR) Abbreviations used in this document to be listed here with the full

More information

INTEGRATED CARE PATHWAY (ICP) FOR THE DYING ADULT

INTEGRATED CARE PATHWAY (ICP) FOR THE DYING ADULT INTEGRATED CARE PATHWAY (ICP) FOR THE DYING ADULT PLEASE INFORM THE PALLIATIVE CARE TEAM ON COMMENCEMENT OF THIS ICP (EXT 8958) ICP Start Date Patient s Name. Ward. Consultant.. Named Specialist Nurse

More information

SYRINGE DRIVER MEDICATIONS

SYRINGE DRIVER MEDICATIONS SYRINGE DRIVER MEDICATIONS Christine Hull & Anita Webb Staff Nurses, Hospice in the Home 2015 Analgesics:- Groups of Medication used in Syringe Drivers Morphine sulphate Diamorphine Oxycodone Alfentanil

More information

This survey aims to look at individual practice and can be completed by any healthcare professional.

This survey aims to look at individual practice and can be completed by any healthcare professional. This survey aims to look at individual practice and can be completed by any healthcare professional. If you have any questions about how this form should be completed please contact Dr Grace Ting (ghlting@doctors.net.uk)

More information

Palliative Care and the Critical Role of the Pharmacist. Arti Thakerar Education/ Palliative Care Peter MacCallum Cancer Centre

Palliative Care and the Critical Role of the Pharmacist. Arti Thakerar Education/ Palliative Care Peter MacCallum Cancer Centre Palliative Care and the Critical Role of the Pharmacist Arti Thakerar Education/ Palliative Care Peter MacCallum Cancer Centre Overview What is palliative care Role of a pharmacist in palliative care Issues

More information

The last days of life in hospital and at home

The last days of life in hospital and at home The last days of life in hospital and at home Beaumont Multi-disciplinary Palliative Care Study Day 28/9/2017 Dr Sarah McLean Consultant in Palliative Medicine St Francis Hospice Beaumont Hospital Overview

More information

Doncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary

Doncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary Doncaster & Bassetlaw Cancer Locality Palliative Core Formulary Approved by Doncaster & Bassetlaw Hospitals NHS Foundation Trust Drugs and Therapeutics Committee. DJ14/2155 Oct 2014 Review date: Oct 2017

More information

ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug

ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug COMMUNITY PRESCRIPTION CHART All entries should be in CAPITAL letters and in indelible black ink. If medications/ doses are stopped, cross through the relevant line clearly to avoid error. GP: PRESCRIBER

More information

SYMPTOM CONTROL IN THE LAST DAYS OF LIFE. Bradford, Airedale, Wharfedale & Craven

SYMPTOM CONTROL IN THE LAST DAYS OF LIFE. Bradford, Airedale, Wharfedale & Craven Bradford, Airedale, Wharfedale & Craven Managed Clinical Network SYMPTOM CONTROL IN THE LAST DAYS OF LIFE Guidelines for Healthcare Professionals Bradford, Airedale, Wharfedale & Craven Signs and symptoms

More information

GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30)

GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30) GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT These guidelines have been produced in collaboration with Dr Lucy Smyth, Consultant in Renal Medicine, Royal Devon and Exeter

More information

Isle of Wight Syringe Driver Compatibility Guidelines

Isle of Wight Syringe Driver Compatibility Guidelines Isle of Wight Syringe Driver Compatibility Guidelines Produced by The Earl Mountbatten Hospice, Isle of Wight Written January 2015, revision due January 2018 This guideline is available as a paper pocketbook

More information

survey Parenteral anti-epileptics What is your experience? May July 2015

survey Parenteral anti-epileptics What is your experience? May July 2015 Parenteral anti-epileptics What is your experience? May July 2015 Number of responses = 99 1a) In patients with pre-existing epilepsy controlled by PO medication that are imminently dying (prognosis

More information

Palliative care for patients with brain cancer

Palliative care for patients with brain cancer Palliative care for patients with brain cancer Lyn Cave Clinical Nurse Specialist Palliative Care Hospital2Home (H2H) Dr Jayne Wood Clinical Lead Palliative Care The Royal Marsden and Royal Brompton Palliative

More information

End Stage Liver Disease Regional Audit Casenote Survey

End Stage Liver Disease Regional Audit Casenote Survey 1. This questionnaire is an audit of clinical documentation of patients who have died of end stage liver disease. If you have any questions about how this form should be completed please contact Dr Grace

More information

Conservative Management of Uraemia

Conservative Management of Uraemia Conservative Management of Uraemia Information for Health Professionals Renal Department The York Hospital and Scarborough Hospital Tel: 01904 725370 For more information, please contact: The Renal Specialist

More information

Care of dying adults in the last days of life. Improving care at the very end of life.

Care of dying adults in the last days of life. Improving care at the very end of life. Care of dying adults in the last days of life Improving care at the very end of life. Foreword We will all experience death, whether it is our own or that of a loved one. The bereaved person s perception

More information

In our patients the cause of seizures can be broadly divided into structural and systemic causes.

In our patients the cause of seizures can be broadly divided into structural and systemic causes. Guidelines for the management of Seizures Amalgamation and update of previous policies 7 (Seizure guidelines, ND, 2015) and 9 (Status epilepticus, KJ, 2011) Seizures can occur in up to 15% of the Palliative

More information

Long Term Care Formulary HCD - 08

Long Term Care Formulary HCD - 08 1 of 5 PREAMBLE Opioids are an important component of the pharmaceutical armamentarium for management of chronic pain. The superiority of analgesic effect of one narcotic over another is not generally

More information

MND Just in Case kit Information for GPs

MND Just in Case kit Information for GPs MND Just in Case kit Information for GPs What is the MND Just in Case kit? 2 Motor neurone disease (MND) is a progressive and terminal disease that results in degeneration of the motor neurones in the

More information

Specialist Palliative Care Audit and Guidelines Group (SPAGG)

Specialist Palliative Care Audit and Guidelines Group (SPAGG) Specialist Palliative Care Audit and Guidelines Group (SPAGG) Clinical Guideline for the Prescribing and Administration of Furosemide via continuous subcutaneous infusion (CSCI) for Heart Failure Patients

More information

Palliative Care. Pocketbook 4

Palliative Care. Pocketbook 4 Nottinghamshire STP EOL Programme Board 2019 Review 2022 Palliative Care Pocketbook 4 Contents Pain Guidelines page 2 Nausea and Vomiting page 9 Inoperable Bowel Obstruction page 10 Constipation page 11

More information

Enhanced Community Palliative Support Services. Lynne Ghasemi St Luke s Hospice

Enhanced Community Palliative Support Services. Lynne Ghasemi St Luke s Hospice Enhanced Community Palliative Support Services Lynne Ghasemi St Luke s Hospice Learning Outcomes Define the different types of pain Describe the process of pain assessment Discuss pharmacological management

More information

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS The benefits of prefilled syringes for palliative care from the hospital pharmacy service In

More information

Anticipatory prescribing and end of life considerations. Dr Stephanie Lippett

Anticipatory prescribing and end of life considerations. Dr Stephanie Lippett Anticipatory prescribing and end of life considerations Dr Stephanie Lippett contents Pain Restlessness/agitation Nausea/vomiting Secretions Syringe driver Anticipatory prescribing Important things to

More information

Regional Breathlessness Audit - Case Note Survey. 1. Introduction. Regional Breathlessness Audit - Case Note Survey. 2.

Regional Breathlessness Audit - Case Note Survey. 1. Introduction. Regional Breathlessness Audit - Case Note Survey. 2. Regional Breathlessness Audit - Case te Survey 1. Introduction Please complete this form for your case note review. Cases used may be PROSPECTIVE AND/OR RETROSPECTIVE. Please log as many cases as you can.

More information

BACKGROUND Measuring renal function :

BACKGROUND Measuring renal function : A GUIDE TO USE OF COMMON PALLIATIVE CARE DRUGS IN RENAL IMPAIRMENT These guidelines bring together information and recommendations from the Palliative Care formulary (PCF5 ) BACKGROUND Measuring renal

More information

EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE EAST LANCASHIRE SPECIALIST PALLIATIVE CARE TEAM EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE Reviewed and updated August 2009 Next review date August 2011 Approved

More information

Coversheet for Network Site Specific Group Agreed Documentation

Coversheet for Network Site Specific Group Agreed Documentation Coversheet for Network Site Specific Group Agreed Documentation This sheet is to accompany all documentation agreed by Pan Birmingham Cancer Network Site Specific Groups. This will assist the Network Governance

More information

Palliative care in long-term conditions Scottish Palliative Care Pharmacists Association

Palliative care in long-term conditions Scottish Palliative Care Pharmacists Association Palliative care in long-term conditions 2011 2012 Scottish Palliative Care Pharmacists Association Aims & Objectives To explore symptoms, general management principles and appropriate palliative treatment

More information

Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC)

Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC) Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC) May 2018 THE WATERLOO WELLINGTON SYMPTOM MANAGEMENT GUIDELINE FOR THE END OF

More information

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES GENERAL PRINCIPLES Neuropathic pain may be relieved in the majority of patients by multimodal management A careful history and examination are essential.

More information

BREATHLESSNESS MANAGEMENT

BREATHLESSNESS MANAGEMENT Guideline Name: Breathlessness BACKGROUND Breathlessness is a common symptom in patients with cancer, end-stage heart failure and end-stage chronic obstructive pulmonary disease (COPD). There are many

More information

PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE Originally produced: July 2006 First Review: August 2009 Second Review: November 2011 For review November 2013 Approved

More information

The pain of it all. Rod MacLeod MNZM. Hibiscus Hospice, Auckland and University of Auckland

The pain of it all. Rod MacLeod MNZM. Hibiscus Hospice, Auckland and University of Auckland The pain of it all Rod MacLeod MNZM Hibiscus Hospice, Auckland and University of Auckland Definition of PAIN An unpleasant sensory and emotional experience which we primarily associate with tissue damage

More information

Care of the dying in End Stage Kidney Disease (ESKD) - Conservative. Elizabeth Josland Renal Supportive Care CNC St George Hospital

Care of the dying in End Stage Kidney Disease (ESKD) - Conservative. Elizabeth Josland Renal Supportive Care CNC St George Hospital Care of the dying in End Stage Kidney Disease (ESKD) - Conservative Elizabeth Josland Renal Supportive Care CNC St George Hospital Introduction What does conservative management look like? How does the

More information

Drug Prescription and Administration Record

Drug Prescription and Administration Record Chart No. this admission Drug Prescription and Administration Record Patient s Name: of Admission: Chart Start : Chart Finish : NHS No: Consultant Code: Ward: ALERT: of Birth: ADDITIONAL CAUTIONS FOR PRESCRIBING

More information

CARE OF THE DYING PATIENT WITH ESKD ELIZABETH JOSLAND - RSC CNC

CARE OF THE DYING PATIENT WITH ESKD ELIZABETH JOSLAND - RSC CNC CARE OF THE DYING PATIENT WITH ESKD ELIZABETH JOSLAND - RSC CNC OBJECTIVES UNDERSTANDING OF: POTENTIAL COMPLEXITIES OF ESKD PATIENTS IMPORTANCE OF COMMUNICATION CONSIDERATIONS AT END-OF-LIFE END-OF-LIFE

More information

Approach to symptom control near the end-of-life

Approach to symptom control near the end-of-life Approach to symptom control near the end-of-life 18 Sept 2011 Dr Alethea Yee Senior Consultant, Department of Palliative Medicine National Cancer Centre,Singapore What is end of life? No precise definition

More information

GUIDELINES FOR THE MANAGEMENT OF PALLIATIVE CARE PATIENTS WITH A HISTORY OF SUBSTANCE MISUSE

GUIDELINES FOR THE MANAGEMENT OF PALLIATIVE CARE PATIENTS WITH A HISTORY OF SUBSTANCE MISUSE GUIDELINES FOR THE MANAGEMENT OF PALLIATIVE CARE PATIENTS WITH A HISTORY OF SUBSTANCE MISUSE 41.1 GENERAL PRINCIPLES The ICD 10 diagnostic criteria for dependency syndrome are listed in Table 41.1 below.

More information

Essential Syringe Driver Training for T 34. Elaine Bird St Luke s Hospice

Essential Syringe Driver Training for T 34. Elaine Bird St Luke s Hospice Essential Syringe Driver Training for T 34 Elaine Bird St Luke s Hospice Aim For all practitioners to be accountable for their individual competence and capability when caring for a resident with a T34

More information

GG&C Chronic Non Malignant Pain Opioid Prescribing Guideline

GG&C Chronic Non Malignant Pain Opioid Prescribing Guideline GG&C Chronic Non Malignant Pain Opioid Prescribing Guideline Background Persistent pain is common, affecting around five million people in the UK. For many sufferers, pain can be frustrating and disabling,

More information

Respiratory Secretions. Care in the last 72 hours of life Paul Tait, pharmacist

Respiratory Secretions. Care in the last 72 hours of life Paul Tait, pharmacist Respiratory Secretions Care in the last 72 hours of life Paul Tait, pharmacist 50% Why? Inability to swallow & clear secretions Ineffective cough Reduced consciousness Pooling of secretions in the throat

More information

Regional Renal Training

Regional Renal Training Regional Renal Training Palliative and End of Life Care Dr Clare Kendall North Bristol NHS Trust Advanced Kidney Disease Dialysis/Transplant Conservative Management Deteriorating despite dialysis/failing

More information

Q&A: Opioid Prescribing for Chronic Non-Malignant Pain

Q&A: Opioid Prescribing for Chronic Non-Malignant Pain NHS Hastings and Rother Clinical Commissioning Group Chair Dr David Warden Chief Officer Amanda Philpott NHS Eastbourne, Hailsham and Seaford Clinical Commissioning Group Chair Dr Martin Writer Chief Officer

More information

Policy/Standard Operating Procedure/ Clinical Guideline. ELHT/CP22 Version 5.1. ELHT/CP22 Version 4.1

Policy/Standard Operating Procedure/ Clinical Guideline. ELHT/CP22 Version 5.1. ELHT/CP22 Version 4.1 TRUST WIDE/DIVISIONAL DOCUMENT Delete as appropriate Policy/Standard Operating Procedure/ Clinical Guideline DOCUMENT TITLE: Policy and Procedure for the T34 Ambulatory Syringe Pump in adults (Palliative

More information

A Brief Guide to Symptom Management and End of Life Care for Children During Pandemic Influenza

A Brief Guide to Symptom Management and End of Life Care for Children During Pandemic Influenza A Brief Guide to Symptom Management and End of Life Care for Children During Pandemic Influenza Background This guidance is intended ONLY for use in situations where health services are overwhelmed and

More information

1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER

1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER 1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER 1.1 GENERAL PRINCIPLES There are many causes of agitation in palliative care patients, which makes recommendations for treatment difficult.

More information

Criteria and Guidance for Referral to Specialist Palliative Care Services

Criteria and Guidance for Referral to Specialist Palliative Care Services Criteria and Guidance for Referral to Specialist Palliative Care Services March 2014 Introduction This guidance is for health professionals caring for patients who may need referral to specialist palliative

More information

Road Blocks in Non-Cancer Palliative Care Obstacles observed from outpatient non-cancer palliative practice.

Road Blocks in Non-Cancer Palliative Care Obstacles observed from outpatient non-cancer palliative practice. Road Blocks in Non-Cancer Palliative Care Obstacles observed from outpatient non-cancer palliative practice. 25th Annual Palliative Education and Research Days, West Edmonton Mall. Edmonton. 2014 Amanda

More information

New Medicines Committee Briefing November 2011 Abstral (sublingual fentanyl citrate tablet) for the management of breakthrough cancer pain

New Medicines Committee Briefing November 2011 Abstral (sublingual fentanyl citrate tablet) for the management of breakthrough cancer pain New Medicines Committee Briefing November 2011 Abstral (sublingual fentanyl citrate tablet) for the management of breakthrough cancer pain Abstral is to be reviewed for use within: Primary Care Secondary

More information

Pain management in palliative care. Dr. Stepanie Lippett and Sister Karen Davies-Linihan

Pain management in palliative care. Dr. Stepanie Lippett and Sister Karen Davies-Linihan Pain management in palliative care Dr. Stepanie Lippett and Sister Karen Davies-Linihan contents Concept of total pain Steps in pain management Recognising neuropathic pain WHO analgesic ladder Common

More information

Opioid rotation or switching may be considered if a patient obtains pain relief with one opioid and is suffering severe adverse effects.

Opioid rotation or switching may be considered if a patient obtains pain relief with one opioid and is suffering severe adverse effects. Dose equivalence and switching between opioids Key Messages Switching from one opioid to another should only be recommended or supervised by a healthcare practitioner with adequate competence and sufficient

More information

News from the National Palliative Care Program

News from the National Palliative Care Program News from the National Palliative Care Program June 2008 Welcome to the Fourth Palliative Care Medicines Working Group Newsletter. The PCMWG meets twice a year and provides advice and guidance to the Department

More information

SHARED CARE GUIDELINE For

SHARED CARE GUIDELINE For SHARED CARE GUIDELINE For Ketamine in Palliative Care Implementation Date: 26.1.2011 Review Date: 26.1.2013 This guidance has been prepared and approved for use within Gateshead in consultation with Primary

More information

Ketorolac injection. Supportive care

Ketorolac injection. Supportive care Supportive care Ketorolac injection Supportive care: specialist medicines This leaflet provides information on a medicine called ketorolac which is used to treat pain that is difficult to control. It is

More information

Guidance for the Use of Subcutaneous Furosemide by Continuous Infusion for Heart Failure in Community Settings

Guidance for the Use of Subcutaneous Furosemide by Continuous Infusion for Heart Failure in Community Settings Guidance for the Use of Subcutaneous Furosemide by Continuous Infusion for Heart Failure in Community Settings NHS Highland Authorised by: Planning For Fairness: Yes/No (Formerly EQIA) Distribution Consultant

More information

Implementing the recommendation on medication management and symptom control

Implementing the recommendation on medication management and symptom control Implementing the recommendation on medication management and symptom control Mike Grocott Professor of Anaesthesia and Critical Care Medicine University of Southampton Consultant in Critical Care Medicine

More information

Berkshire West Area Prescribing Committee Guidance

Berkshire West Area Prescribing Committee Guidance Guideline Name Berkshire West Area Prescribing Committee Guidance Date of Issue: September 2015 Review Date: September 2017 Date taken to APC: 2 nd September 2015 Date Ratified by GP MOC: Guidelines for

More information

Palliative Care. Anticipatory Prescribing Guidelines & June Gippsland Region Palliative Care Consortium Clinical Practice Group

Palliative Care. Anticipatory Prescribing Guidelines & June Gippsland Region Palliative Care Consortium Clinical Practice Group Palliative Care Anticipatory Prescribing Guidelines June 2016 Gippsland Region Palliative Care Consortium Clinical Practice Group Policy No. Title Keywords Ratified GRPCC-CPG008_1.1_2016 Anticipatory Prescribing

More information

patient group direction

patient group direction MORPHINE SULPHATE (Oral) v01 1/8 MORPHINE SULPHATE (Oral) PGD Details Version 1.0 Legal category Staff grades Approved by POM Paramedic (Non-ECP) Nurse (Non-ECP) Emergency Care Practitioner (Paramedic)

More information

Symptom Control in the Community Setting. Dr Andrew Tysoe-Calnon

Symptom Control in the Community Setting. Dr Andrew Tysoe-Calnon Symptom Control in the Community Setting Dr Andrew Tysoe-Calnon Lead Consultant t Common symptoms Pain Agitation Shortness of breath Nausea and vomiting Intestinal obstruction Confusion Pain Occurs in

More information

PALLIATIVE CARE PRESCRIBING FOR PATIENTS WHO ARE SUBSTANCE MISUSERS

PALLIATIVE CARE PRESCRIBING FOR PATIENTS WHO ARE SUBSTANCE MISUSERS PALLIATIVE CARE PRESCRIBING FOR PATIENTS WHO ARE SUBSTANCE MISUSERS Background information Substance misusers who develop palliative care needs are likely to have psychological, social and existential

More information

Using syringe pumps in palliative care

Using syringe pumps in palliative care Using syringe pumps in palliative care Facilitator: Barbara Stone RN Ground rules Medication matching game Learning outcomes To identify the indications for using a syringe pump To discuss the general

More information

Dementia & Palliative Care

Dementia & Palliative Care Dementia & Palliative Care Aspiration, Myth or Reality? A Clinicians Perspective... Lesley Jones Advanced Practitioner Dementia Care Dementia Dementia is a chronic progressive mental disorder that adversely

More information

Acute pain management in opioid tolerant patients. Muhammad Laklouk

Acute pain management in opioid tolerant patients. Muhammad Laklouk Acute pain management in opioid tolerant patients Muhammad Laklouk General principles An adequate review and assessment Provision of effective analgesia (including attenuation of tolerance and hyperalgesia)

More information

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care If possible patients should be assessed using a simple visual analogue scale VAS to determine the most appropriate stage

More information

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti- Page 1 of 8 Analgesia The World Health Organisation (WHO, 1990) has devised a model to assist health care professionals in the management of cancer pain. The recommendations include managing pain, by the

More information

Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04

Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04 Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04 Date issued Issue 1 Nov 2018 Planned review Nov 2021 PPT-PGN 18 part of NTW(C)38 Pharmaceutical

More information

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients.

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients. We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients. The closing date for responses is 19th December The results

More information

Scottish Medicines Consortium

Scottish Medicines Consortium Scottish Medicines Consortium fentanyl 50 micrograms / dose, 100 micrograms/dose, 200 micrograms / dose nasal spray (Instanyl ) No. (579/09) Nycomed UK Ltd 09 October 2009 The Scottish Medicines Consortium

More information